Early warning systems (EWS), used to identify deteriorating hospitalised patients, are based on measurement of vital signs. When the patients are pregnant, most EWS still use non-pregnant reference ranges of vital signs to determine trigger thresholds. There are no published reference ranges for all vital signs in pregnancy. We aimed to define vital signs reference ranges for term pregnancy in the preoperative period, and to determine the appropriateness of EWS trigger criteria in pregnancy. We conducted a one-year retrospective study in a tertiary referral obstetric hospital. The study sample was healthy term women undergoing planned caesarean section (CS). Systolic blood pressure (SBP), diastolic blood pressure (DBP), heart rate (HR), oxygen saturation (SpO 2 ) and temperature were all measured automatically and data was extracted from the medical record. Two hundred and fifty-eight women met inclusion criteria. Results were (mean ± SD [standard deviation]) SBP 118 ± 11.2 mmHg, DBP 75 ± 10.3 mmHg, HR 84 ± 10.2 /minute, respiratory rate 18 ± 1.5 /minute, SpO 2 99% ± 1.0% and temperature 36.4°C ± 0.43°C. The reference ranges (mean ± 2SD) determined were SBP 96-140 mmHg, DBP 54-96 mmHg, HR 64-104/minute, RR 15-21 /minute, SpO 2 97%-100% and temperature 35.5°C-37.3°C. This study defined a reference range for vital signs in healthy term pregnant women undergoing CS. Study findings suggest that currently used criteria for EWS triggers, based on non-pregnant values, may be too extreme for timely detection of deteriorating pregnant patients. Further research examining the modified HR triggers of ≤50 and ≥110 /minute in pregnant women and their relationship to clinical outcomes is required.
Introduction
Recent confidential enquires into maternal death 1, 2 have documented that the early recognition of critically ill pregnant women has been substandard and this has been highlighted as an area for improvement. Early warning systems (EWS) that detect alterations in physiological variables are often used to predict pregnant or recently pregnant women who may become unwell. However the interpretation of alterations in physiological values depends upon the availability of robust reference limits or reference ranges for the variables being measured. A reference range is defined as a set of values, for the particular variable being measured, in which 95% of the normal healthy population falls. As such it only includes the healthy population i.e. healthy pregnant women. The number of data points typically required to determine a reference range for a particular variable is 120 3 . There are few published reference ranges in journal publications or textbooks for all vital signs (systolic and diastolic blood pressure, heart rate, respiratory rate, oxygen saturation and temperature) in term pregnant women. Instead, non-pregnant vital sign reference ranges are used to define normal and abnormal vital sign values in pregnant women. Given that there are such remarkable maternal physiological changes and adaptations that take place over the course of pregnancy to facilitate foetal growth and survival, these non-pregnant reference values are likely to vary from those considered normal in the third trimester, and therefore are not a reliable comparison. Given that the reference ranges for all vital sign values in pregnant women have not been published, it is possible that this poor recognition may be due to a misunderstanding or lack of understanding of what appropriate vital sign values are in pregnant women. There are many different emergency warning systems used in different hospital settings; these include the Medical Emergency Team (MET) call system [4] [5] [6] , the Modified Early Warning System/Score (MEWS) and the Modified Early Obstetric Warning System/ Score (MEOWS) 7, 8 . The trigger thresholds for emergency system responses in pregnant women, such as those used in these warning systems are based on reference ranges that have not been established in pregnant women (Table 1) . This may contribute to these systems' limitations when applied to pregnant women. The establishment of vital sign reference ranges for healthy pregnant women will provide observational evidence for the generation of correct trigger thresholds and help to inform clinicians regarding abnormal vital sign values in pregnant women. It may also assist with the earlier recognition of deteriorating pregnant women, facilitating earlier treatment and correction of the underlying abnormality. Given this gap in the knowledge related to these important clinical observations in pregnant women, we undertook a study to determine the reference ranges of vital signs in healthy term pregnant women.
Methods
After institutional ethics approval (21 October 2014, Royal Women's Hospital Research Committee and Royal Women's Hospital Human Research Ethics Committee), during the period February-June 2015, we conducted a single centre (The Royal Women's Hospital, Melbourne, Victoria) retrospective study examining histories from women who underwent planned CS over a 52 week period (1 January to 31 December 2014). We chose to retrieve data from the preoperative record in women undergoing planned CS because, in our institution, this is the time when vital signs are recorded routinely in all women and therefore women undergoing CS provide an excellent patient group from which to determine reference ranges of vital signs.
Inclusion criteria were pregnant women 18-45 years of age, ≥37 weeks gestation, singleton pregnancy, undergoing planned CS, and healthy American Society of Anesthesiologists (ASA) I or II. Exclusion criteria were body mass index (BMI) at booking >30 kg/m 2 or full-term BMI >35 kg/m 2 , smoking, illicit drug use, alcohol abuse, in labour, or undergoing emergency CS.
Following patient selection, individual medical records were reviewed for the following information: The measurement of vital signs was performed by trained perioperative nurses using standardised automatic monitoring systems (Spot Vital Signs® with Nellcor pulse oximetry, WelchAllyn, NY, USA) to measure non-invasive systolic and diastolic blood pressure, heart rate, and oxygen saturation. Respiratory rate was measured manually by counting the respiratory rate over a minute. Temperature was measured using a tympanic thermometer (Genius™ 2 AccuSystem, Covidien, MA, USA). Vital sign measurements were made in the seated position at rest after history taking and examination were performed. Data was recorded in the preoperative record and retrieved by the study investigator (LH).
Results
From 1 January to 31 December 2014, 258 women met the study criteria. Of these 226 (87.6%) were classified as ASA class I, and 32 (12.4%) were classified as ASA class II. Table 2 shows the obstetric and demographic characteristics of the sample study. The study sample represented a wide range of ethnicity ( Table 2) . Indications for the CS were: 159 (62%) for repeat CS, 47 (18%) for breech presentation, 45 (17%) for elective CS (reasons such as foetal macrosomia, prior traumatising vaginal birth, vaginismus, maternal anxiety, placenta praevia), four (1.6%) for foetal cardiac abnormalities (supraventricular tachycardia, heart block, transposition of the great arteries), one (0.4%) for post-maturity, one (0.4%) for failed induction of labour (not in labour) and one (0.4%) for vasa praevia. Two hundred and fifty-five (99%) women underwent CS with neuraxial anaesthesia (spinal [247 women], combined spinal epidural anaesthesia [eight women]) and three (1%) women underwent CS with general anaesthesia (maternal request). Fifteen women (6%) experienced a postpartum haemorrhage of ≥750 ml (mean postpartum haemorrhage volume 878 ± 147.5 ml). There were no complications related to anaesthesia and no admissions to higher acuity areas for maternal medical problems. Table 3 shows the values for vital signs in the group. The reference range was determined by calculating two standard deviations above and below the mean study variable. Data are shown with the trigger threshold used in the MET, MEWS and MEOWS systems [4] [5] [6] 7, 8 . The upper and lower trigger thresholds for systolic blood pressure, heart rate, and respiratory rate used by the specifically obstetric designed MEOWS are all beyond three standard deviations of our study reference range values.
Discussion
Using a sample of 258 pregnant women, this study determined the reference ranges of SBP, DBP, HR, RR, SpO 2 and temperature in healthy term pregnant women. To the best of our knowledge, this is the first study to define all parameters of vital signs in a large group of healthy term pregnant women. Previous studies have only focused on one vital sign parameter. Our findings suggest that the upper and lower limit triggers used in emergency obstetric warning systems may be too extreme to detect deteriorating patients in a timely manner. When considering heart rate, often the first vital sign to change as the result of obstetric haemorrhage, the trigger threshold used in current EWS is 120 /minute, which from our current study is greater than three standard deviations above our sample mean.
This study has further contributed to the large-scale Avon Longitudinal Study of Parents and Children (ALSPAC)based BP study where blood pressure data was obtained retrospectively 9 . Although the ALSPAC study was a valuable contribution to the literature, it was performed in a homogenetic population. Our study consists of a diverse patient group, therefore, the results may lend themselves to being more widely applicable across some ethnicities.
Medical Rapid Response Systems/Early Warning Systems
Many hospitals employ a rapid response system/score or EWS, to alert staff members to deteriorating patients requiring immediate medical attention. Their purpose is to prevent a patient reaching a critical situation by being vigilant to signs of deterioration. Once vital sign criteria are met, having strayed from within a range that is deemed to be normal/safe, an emergency team call may be made. These EWS are widely used in Australasia, North America and the United Kingdom 10 . In Australia, this triggers a MET call, however there are various versions of this, often referred to as a MEWS call in the United Kingdom, Sweden and New Zealand. There is also a pregnancy-specific MEOWS that triggers a MEOWS call. The concept of MEOWS was created a decade ago. Whilst widely adopted in the UK, it is less commonly utilised elsewhere in the world. EWS criteria for non-pregnant individuals are often applied to pregnant patients as well 11 . In terms of the effectiveness of EWS, there is evidence that EWS have a strong predictive value for death and cardiorespiratory arrest within 48 hours [12] [13] [14] [15] . Singh et al reported MEOWS to have a positive predictive value of 39% (95% confidence interval [CI] 32%-46%) and a negative predictive value of 98% (95% CI 96%-99%) 16 . The MEOWS has demonstrated a higher sensitivity than non-obstetric EWS, 89% (95% CI 81%-95%) 16 . Broadening the trigger thresholds could potentially increase MEOWS sensitivity. This would achieve a reduction in false negatives, but may elevate false positives, therefore reducing specificity 16 . Specificity of MEOWS has been reported as 79% (CI 76%-82%). This is comparable to non-obstetric EWS and has opportunity for improvement. Specificity is highly desirable in the interests of efficient resource utilisation. Previous research has called for refinement of cut-off values for triggering an EWS in order to reduce the false positive rates 16 . However, whilst a false positive is undesirable and increases resource burden, a false negative could have a disastrous outcome. Thus, a system that preferences sensitivity over specificity is favourable.
Heart rate
Maternal HR increases early in pregnancy and continues to gradually rise until the third trimester 17, 18 . Evidence suggests that by the third trimester, the maternal HR is elevated by 15-20 per minute compared to pre-pregnant values 19 . The American Heart Association states the normal HR for a non-pregnant individual is 60-100 /minute 20 . Our study characterised the reference range for HR in term pregnant women to be 64-104 /minute and the average HR as 84 ± 10.2 /minute. Finding similar average values were van Oppen et al (92 /minute) 21 and San Frutos et al (85.5 /minute) 19 23 and Zentner et al (73 /minute) 24 reported slightly lower HR. With a sample size of 258, the current study is the largest to date that has reported a normal range of HR in term pregnant women.
Cardiac disease, including hypertension, and obstetric haemorrhage are major causes of maternal morbidity and mortality. Recognition of an unwell pregnant woman with cardiac disease or haemorrhage relies on clinical examination findings. Heart rate changes are an early marker of haemorrhage and heart failure, therefore understanding what the normal HR range is in term pregnant women is important. According to our study, the normal HR in term pregnant women is 64-104 /minute. The observed upper limit of the scale (104 /minute) is significantly lower than the current EWS trigger to initiate a MEOWS call (120 /minute) for tachycardia. Using data from our study, the upper limit of 120 /minute is more than three standard deviations above the mean value for healthy pregnant women. Furthermore, the observed range for HR found in our study may be an overestimation due to preoperative anxiety. Using current EWS criteria, once a HR of ≤40 or ≥120 /minute is reached, haemodynamics are likely to be highly unstable. Based on this study, consideration of a lower limit HR of ≤50 instead of ≤40, and an upper limit HR of ≥110 instead of ≥120 warrants further investigation as threshold triggers for activation of alerts in an EWS. This would increase sensitivity but reduce specificity of MEOWS, with the aim of identifying at risk patients before their condition is critical. The impact of non-obstetric EWS and obstetric EWS on longer term health outcomes and their use of resources still remains unclear and is an area for further study.
Systolic blood pressure and diastolic blood pressure
Pregnancy is a high output state with the maintenance of adequate BP vital to ensure sufficient placental and therefore foetal perfusion, as well as meeting maternal needs. The reference range that this study determined for SBP was 96-140 mmHg and DBP was 54-96 mmHg. This study indicated that the average SBP in full term pregnant women was 118 ± 11.2 mmHg and DBP was 75 ± 10.3 mmHg. This SBP is in agreement with the American Heart Association recommendation as an ideal BP in non-pregnant individuals (<120/80 mmHg) 25 and the reference range is consistent with definitions of hypertension in pregnancy 26 . It is also consistent with Macdonald et al in 2015 who published data from the ALSPAC study 27 where BP readings were extracted retrospectively from patient antenatal visit records. Similar to HR, the observed range for SBP and DBP in our study may be an overestimation due to preoperative anxiety.
Respiratory rate and oxygen saturation
Minute ventilation is a product of both tidal volume and RR. Minute ventilation increases in pregnancy by 20%-50% 28 . There is a scarcity of literature defining a normal RR and SpO 2 in non-pregnant and pregnant individuals. The RR reference range stated by Johns Hopkins Medicine is 12-16 breaths per minute for non-pregnant individuals 29 . However, others quote non-pregnant RR as 15-20 breaths per minute 30 , conflicting with reports that it is 14-15 breaths per minute 31 . The limited literature in this area is unclear. We demonstrated that an average RR in term pregnant women was 18 ± 1.5 breaths per minute and the RR reference range was 15-21 breaths per minute. Teli et al in 2013 32 reported a RR of 26 breaths per minute in term pregnant women, seeming excessively high, whilst Pernoll reported a RR of 14 breaths per minute in a study of 12 women 31 . Our study represents a much larger sample size than the previous studies. However, it is possible that the RR characterised in our study was under the influence of anxiety, which may have elevated the RR due to shallower and more rapid breathing. Additionally as RR was a manual measurement-i.e. not measured by an automated machine-there may be measurement error. Oxygen saturation is an important tool for perioperative monitoring of patients. We determined that mean SpO 2 in term pregnant women was 99% ± 1.0%.
Temperature
This study clarified a body temperature reference range in healthy full term pregnant women. During pregnancy there are two main sources of increased heat production. Firstly, maternal metabolic rate is increased by approximately 15% and secondly, additional heat is released by the growing foetus and uteroplacental tissue 33, 34 . Maternal temperature changes in pregnancy remain a point of contention. It was long thought that maternal core temperature was increased throughout pregnancy 35, 36 . This study illustrated that the average temperature in term pregnant women was 36.4°C ± 0.43°C. A reference range was demonstrated to be 35.5°C-37.3°C.
Our study is limited by the retrospective nature of the data collection with incomplete recording of all vital signs in all women, and the observer variability especially with respect to the measurement of respiratory rate. The values obtained in this study represent values taken immediately before CS and so may not be translatable outside the preoperative period. This study does not explore the relationship between vital sign values and clinical outcomes and so further studies are needed to investigate these very important relationships.
Conclusion
This observational study has determined the ranges of vital signs in healthy term pregnant women on the day of their CS and was undertaken to help inform what abnormal vital signs are and therefore what the obstetric EWS criteria should be in this group of women. There are physiological alterations in pregnancy that have a measurable effect on vital signs. This study defined a reference range for vital signs in healthy term pregnant women, which may enable clinical decision-making based on observational data. Study findings suggest that the currently used criteria for heart rate may be too extreme for timely detection of deteriorating patients. Further research examining the modified HR triggers ≤50 and ≥110 /minute in pregnant women and their relationship to clinical outcomes is required.
